Targeting of thrombolytic agents: current state of knowledge and perspectives.
Torchilin
V P
VP
Center for Imaging and Pharmaceutical Research, Massachusetts General Hospital, East Charlestown 02129.
D000818:Animals; D000906:Antibodies; D004337:Drug Carriers; D005340:Fibrinogen / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D008081:Liposomes; D008280:Magnetics; D013917:Thrombin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D013927:Thrombosis / Q000188:drug therapy / Q000378:metabolism
D000906:Antibodies; D004337:Drug Carriers; D005343:Fibrinolytic Agents; D008081:Liposomes; D005340:Fibrinogen; D013917:Thrombin